Patents by Inventor Shisen Wang

Shisen Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrazole compounds
    Patent number: 6436915
    Abstract: Pharmaceutical compositions and compounds are provided. The compounds of the invention have anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death. In one embodiment of the invention, formulations of the compounds in combination with a physiologically acceptable carrier are provided. The pharmaceutical formulations are useful in the treatment of hyperproliferative disorders, which disorders include tumor growth, lymphoproliferative diseases, angiogenesis. The compounds of the invention are substituted pyrazoles and pyrazolines.
    Type: Grant
    Filed: December 22, 2000
    Date of Patent: August 20, 2002
    Assignee: Kinetek Pharmaceuticals, Inc.
    Inventors: Zaihui Zhang, Timothy Scott Daynard, Shisen Wang, Mikhail Chafeev
  • Antiproliferative 1,2,3-thiadiazole compounds
    Patent number: 6420400
    Abstract: Pharmaceutical compositions and compounds are provided. The compounds of the invention have anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death. In one embodiment of the invention, formulations of the compounds in combination with a physiologically acceptable carrier are provided. The pharmaceutical formulations are useful in the treatment of hyperproliferative disorders, which disorders include tumor growth, lymphoproliferative diseases, angiogenesis.
    Type: Grant
    Filed: April 7, 2000
    Date of Patent: July 16, 2002
    Assignee: Kinetek Pharmaceuticals, Inc.
    Inventors: Zaihui Zhang, Jun Yan, Danny Leung, Shisen Wang, Penelope C. Costello, Jasbinder Sanghera
  • Pyrazole compounds
    Publication number: 20020042501
    Abstract: Pharmaceutical compositions and compounds are provided. The compounds of the invention have anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death. In one embodiment of the invention, formulations of the compounds in combination with a physiologically acceptable carrier are provided. The pharmaceutical formulations are useful in the treatment of hyperproliferative disorders, which disorders include tumor growth, lymphoproliferative diseases, angiogenesis. The compounds of the invention are substituted pyrazoles and pyrazolines.
    Type: Application
    Filed: December 22, 2000
    Publication date: April 11, 2002
    Inventors: Zaihui Zhang, Jun Yan, Danny Leung, Penelope C. Costello, Jasbinder Sanghera, Timothy Scott Daynard, Shisen Wang, Mikhail Chafeev